Home

NICE insiders criticise Alzheimer's drug decision

2006-10-19T00:00:00

The National Institute for Health and Clinical Excellence has been criticised by its own senior advisers for not listening to experts when deciding to limit the use of the only drugs available in the UK for Alzheimer's disease.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here